metother
accord healthcare b.v. - metotreksatas - injekcinis tirpalas užpildytame švirkšte - 50 mg/ml - methotrexate
celvapan
nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vakcinos - a (h1n1) v 2009 viruso sukeltos gripo profilaktika. celvapan turėtų būti naudojami laikantis oficialių rekomendacijų.
macmiror complex
mra, uab - nifuratelis/nistatinas - makšties kremas - 500 mg/200000 tv; 100 mg/40000 tv/g - other antiinfectives and antiseptics
macmiror complex
adeofarma, uab - nifuratelis/nistatinas - makšties minkštosios kapsulės - 500 mg/200000 tv - other antiinfectives and antiseptics
macmiror complex
medlinija, uab - nifuratelis/nistatinas - makšties minkštosios kapsulės - 500 mg/200000 tv - other antiinfectives and antiseptics
macmiror complex
tojaris projektai, uab - nifuratelis/nistatinas - makšties minkštosios kapsulės - 500 mg/200000 tv - other antiinfectives and antiseptics
macmiror complex
lex ano, uab - nifuratelis/nistatinas - makšties minkštosios kapsulės - 500 mg/200000 tv - other antiinfectives and antiseptics
briliantinis žaliasis valentis
valentis, uab - briliantinis žaliasis - odos tirpalas - 10 mg/ml - other antiseptics and disinfectants
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenija, idiopatinė - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
adakveo
novartis europharm limited - crizanlizumab - anemija, sirupo ląstelė - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.